Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Офтальмология / Английские материалы / Myopia Animal Models to Clinical Trials_Beuerman, Saw, Tan_2009.pdf
Скачиваний:
0
Добавлен:
28.03.2026
Размер:
3.4 Mб
Скачать

Myopia

Animal Models to Clinical Trials

This page intentionally left blank

Myopia

Animal Models to Clinical Trials

editors Roger W. Beuerman

Seang-Mei Saw Donald T. H. Tan Tien-Yin Wong

Singapore Eye Research Institute Singapore National Eye Centre National University of Singapore

World Scientific

N E W J E R S E Y L O N D O N S I N G A P O R E B E I J I N G S H A N G H A I H O N G K O N G TA I P E I C H E N N A I

Published by

World Scientific Publishing Co. Pte. Ltd.

5 Toh Tuck Link, Singapore 596224

USA office: 27 Warren Street, Suite 401-402, Hackensack, NJ 07601

UK office: 57 Shelton Street, Covent Garden, London WC2H 9HE

Library of Congress Cataloging-in-Publication Data

Myopia : animal models to clinical trials / editors, Roger W. Beuerman ... [et al.]. p. ; cm.

Includes bibliographical references and index. ISBN-13: 978-981-283-297-9 (hardcover : alk. paper) ISBN-10: 981-283-297-1 (hardcover : alk. paper)

1. Myopia. I. Beuerman, Roger W., 1942–

[DNLM: 1. Myopia. 2. Clinical Trials as Topic--methods. 3. Disease Models, Animal. WW 320 M9962 2010]

RE938.M963 2010 617.7'55--dc22

2010010940

British Library Cataloguing-in-Publication Data

A catalogue record for this book is available from the British Library.

Copyright © 2010 by World Scientific Publishing Co. Pte. Ltd.

All rights reserved. This book, or parts thereof, may not be reproduced in any form or by any means, electronic or mechanical, including photocopying, recording or any information storage and retrieval system now known or to be invented, without written permission from the Publisher.

For photocopying of material in this volume, please pay a copying fee through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA. In this case permission to photocopy is not required from the publisher.

Typeset by Stallion Press

Email: enquiries@stallionpress.com

Printed in Singapore.

Foreword

The field of myopia research is curiously different from research into the etiology of other medical conditions. Whereas for most conditions, research on animals models is universally held to be essential for understanding the etiology and promising treatment modalities, in the case of myopia there is little cross-over from laboratory to clinic, despite the dramatic findings that animals can be made myopic or hyperopic in compensation for defocus imposed by spectacle lenses — a result consistent with the prevalence of other diseases being associated with homeostatic mechanisms. Why this disconnect between animal and clinical studies of myopia? One likely cause is the strong association of the prevalence of myopia with educational level, making it seem to be a uniquely human disorder. This association has led to speculative conjectures about how myopia develops, but has not led to effective prophylaxis. As a result of this lack of therapeutic progress, some have rejected the possibility of arresting myopia by relatively non-invasive visual treatments. Despite several decades of experimental studies of myopia in animals, many clinicians continue to consider myopia as a particularly human conditions, or as a consequence of one’s genetic makeup, and regard the animal studies as only weakly

v

vi Foreword

related to why humans become myopic. Given that every few years a new group of animals is added to the myopia zoo, all compensating for defocus imposed by spectacle lenses, how likely is it that humans are different?

Were the etiology of human myopia simple this controversy would have been resolved by now. But many human diseases, such as cardiovascular disease and diabetes, have a complex etiology, involving both genetic and behavioral components. How do they differ from myopia? One reason may be that these diseases can be effectively treated without fully understanding their underlying causes, whereas in the case of myopia, understanding the cause of the myopia may well be necessary because simply correcting the myopia may reinstate the conditions that caused the myopia in the first place, thereby setting in motion a positive feedback loop, resulting in an iatrogenic worsening of the myopia. Indeed, some of the possible treatments (scleral reinforcement, daily atropine administration) might be worse than the disease, at least for otherwise healthy children with mild myopia.

Only now are we beginning to appreciate and measure in children the parameters likely to be important indicators of the initiation and progression of the myopia development. For example, what is the refractive status of the retinal periphery and how is it affected by visual experience? Does the periphery become hyperopic relative to the fovea as a cause or consequence of the fovea becoming myopic? Does intensive reading first affect the central or peripheral refractions? How much of the variability in peripheral refractions is a function of eye-shape at birth vs the visual surroundings, and how do these interact? If medical students are more likely to become myopic than athletes, is this due to the total amount of reading or to the duration of episodes of reading? Or to the amount of time outdoors? If the latter, is the relevant factor the absence of hyperopic or myopic defocus at the fovea or in the periphery, or perhaps the enhanced stimulation of dopamine by bright light? These are issues that can be studied in both humans and animals, but require experimental manipulations more difficult than those that have been attempted to date.

An unfortunate consequence of the complicated, multifactorial, nature of the control of eye growth and development of refractive state is that the field of research has been nearly completely divided into those doing animal research and those doing human research. My dear friend and colleague, the late Sek-Jin Chew, was an exception. He studied muscarinic receptors in different ocular tissues to understand why atropine reduced myopic progression. He studied the blinking of chicks to understand whether brief pulses of increased intraocular pressure would affect ocular

vii Foreword

elongation. And he raised mice wearing a diffuser over one eye under his bed to explore whether mice might be a useful animal model for myopia research because of the variety of genetic manipulations available. When he returned from New York to Singapore he initiated both epidemiological and animal research that led to Singapore becoming one of the world’s leading centers of myopia research. We hope this volume will be a step in the direction of bringing together the fields of animal and epidemiological research into the etiology of myopia.

Josh Wallman

Department of Biology

City University of New York

USA

Professor Sek-Jin Chew

Dedication

to the Late Professor Sek-Jin Chew

The late Professor Sek-Jin Chew was the first Singapore ophthalmologist to be awarded the Fellow College of Surgeons of Edinburgh (FRCS Ed) Gold Medal, as well as MS and PhD degrees. In 1993, he left Singapore to pursue a PhD in the USA in the midst of a promising clinical career in pursuit of his dream in research. As the first full-time medical staff of the Department of Ophthalmology in the National University Hospital (NUH), he had blazed the trail by devoting his career to full-time research, leading by example in showing how research should and must be integral to the future of ophthalmology in Singapore. From the start, he clearly identified that his research focus would primarily be dedicated to myopia, with a goal towards contributing to our knowledge of causation, and the ultimate development of new approaches towards retarding myopia progression.

After obtaining his Master’s (in anatomy) from the Louisiana State University Eye Center in the USA, he went on to attain his PhD degree (in neuroscience) at the Rockefeller University in 1996. Upon his return, he immediately set to work in getting the Singapore Eye Research Institute (SERI) underway.

In those early days, he worked day and night writing grant proposals to the National Medical Research Council (NMRC), recruiting scientists locally and overseas, and cajoling medical students to participate in projects. At the same time, he was networking with industry and overseas research collaborators to build a name for Singapore as the potential hub for eye research in Asia.

It was at one of those overseas meetings that Sek-Jin fell ill, collapsed, and was discovered to have an inoperable brain tumour. Most people would have resigned themselves to fate and would have given up, but not Sek-Jin. He worked even harder and faster, knowing that he was living on borrowed time. Within a very short time, he was able to assemble funds to the tune of

ix

xDedication

S$20 million as a five-year grant from the NMRC. At the same time, he set up the SERI laboratories in the National University of Singapore (NUS) and built up a team of researchers and support staff from scratch, opening myopia research clinics. On top of that, he was seeing an increasing number of patients, recruiting school children for his myopia trials, as well as establishing successful links and clinical trials with top industry firms such as Bausch and Lomb, CIBA Vision, and others, which continue to this day.

However, I believe that it was not his brilliant academic achievements or his lightning speed in getting things done that has touched our lives the most. I believe all of us will best remember Sek-Jin for his fearless courage, his boundless optimism in coping with his brain tumour, his total devotion to his work, in spite of his terminal condition, his genuine friendship, and the interest and concern shown to even the most junior medical students.

In recognition of his work in myopia research, Sek-Jin was appointed to a number of international organisations. He was Vice President of the Myopia International Research Foundation and the Director of its AsiaPacific headquarters, based in Singapore. He was also appointed Visiting Professor at the City University of New York and the New York Eye and Ear Infirmary, as well as Visiting Scientist at the Rockefeller University. Sek-Jin was also awarded the SNEC Gold Medal Award in 1997 and the SNEC International Gold Medal posthumous Award in recognition of his achievements internationally.

In his short lifespan, Sek-Jin published over 50 papers. He also made more than 150 presentations, mainly in the field of myopia research, in regional and international conferences, and in particular at the world’s foremost research meeting.

Sek-Jin played a pivotal role in establishing links between SNEC and top universities in the USA, such as Harvard with its strong emphasis in myopia research, and Johns Hopkins University in a collaborative myopia study on RGP lens. He was constantly bringing in top scientists from the USA, UK, Australia, Japan, Taiwan, and China, just to name a few, to create opportunities to start new areas of collaboration into the 21st century.

Donald T.H. Tan

FRCSG, FRCSEd, FRCOphth, FAMS

Medical Director, Singapore National Eye Centre

Chairman, Singapore Eye Research Institute

Professor of Ophthalmology

Yong Loo Lin School of Medicine

National University of Singapore

xi Dedication

“My dear friend and colleague, the late Sek-Jin Chew, was an exception. He studied muscarinic receptors in different ocular tissues to understand why atropine reduced myopic progression. He studied the blinking of chicks to understand whether brief pulses of increased intraocular pressure would affect ocular elongation. And he raised mice wearing a diffuser over one eye under his bed to explore whether mice might be a useful animal model for myopia research because of the variety of genetic manipulations available. When he returned from New York to Singapore, he initiated both epidemiological and animal research that led to Singapore becoming one of the world’s leading centers of myopia research.

Professor Josh Wallman

Department of Biology

City College, CUNY, USA

Dr Sek-Jin Chew who was also my student, was my friend and a leader of research at the National University of Singapore. We founded the Singapore Eye Research Institute (SERI) of which he was the founding deputy director. Sek-Jin’s intense interest in myopia has made Singapore one of the world’s leading centers for myopic studies.”

Professor Arthur S.M. Lim

Founding Chairman

Singapore Eye Research Institute

“I first met Sek-Jin here in Singapore at the WOC in 1988; he had a dream to become the first clinician-scientist in Singapore and to establish an eye research institute here. He achieved both goals in a remarkably short-time and it is a great honor for all of us to recognize that his dream has taken root and grown. Sek and Esther were married while he worked in my lab in the US and they became dear friends.

Roger W. Beuerman

Singapore Eye Research Institute

Duke-NUS

SRP Neuroscience and Behavioral Disorders

Yong Loo Lin School of Medicine

National University of Singapore

xii Dedication

Despite the onset of a fatal illness, he continued to direct the institute, organize its programmes, and produce a flood of ideas to encourage his team.”

Dr J.F. Cullen

Royal College of Surgeons of Edinburgh Newsletter

No. 55, Singapore 1999

There are a lot of capable people, but few are both capable and respectable like Sek-Jin…. He was visionary, selfless, and both a good team leader and team player. One of his favorite quotes was, ‘Let’s work together.”’

Professor Dennis Lam

Chairman

Department of Ophthalmology

and

Visual Sciences of the Chinese University of Hong Kong

Hong Kong

Sek-Jin was a dedicated and highly motivated researcher who did not spare himself even when he knew that a brain tumour threatened his long-term future. He directed SERI up until his life was cruelly cut short. Together in New York, Glasgow and in Singapore, Sek-Jin and I put together a plan for what became the Singapore Eye Research Institute. It is a sadness that he was not spared to see the flowering of the seed that was planted at that time.

Wallace S. Foulds, CBE, MD, ChM

DSc (Hon), FRCS (Eng & Glasg), FRCOphth

Singapore Eye Research Institute

Singapore

University of Glasgow

United Kingdom

Message

Myopia: Clinical Analysis to Animal Models

Dedicated to the late Professor Sek-Jin Chew

Myopia has for some years been of great concern to Singaporeans because of its increased incidence, especially among the Chinese.

The prevalence of myopia in Singapore now ranges from 25% to 50% among students, and up to 80% among undergraduates. Paradoxically, this problem also presents ophthalmologists with opportunities to make significant contributions.

The problem of myopia is complex. We are still unclear in biological terms how myopia occurs. Is it due to the collagen at the posterior pole? Is this collagen different from that present in the rest of the sclera? What is the role of retinal pigment epithelium? The application of molecular and cell biology may lead to some answers to the numerous questions regarding the etiology of myopia.

A worrying medical point is that when myopia is high, e.g. six dioptres or more, degenerative changes may develop in the retina affecting the macula and leading to poor vision in middle age or peripheral retinal degeneration may occur leading to retinal tear and detachment.

We have known for many years that myopia tends to run in families and genetic studies will be valuable. What environmental factors aggravate myopia? Is myopia associated with prolonged use of the computer or with prolonged reading? Will eye exercises help? Will genetic therapy help? Do we know of factors that can slow down the progress of myopia? There are numerous unanswered questions.

Myopia is more common among the Chinese. “Why?” The late Professor Ida Mann noted that the hunters of Europe like the Germans and the aborigines of Australia were not myopic because if they could see

xiii

xiv Message

far, they would not survive. In contrast, Chinese scholars, craftsmen and artists engaged in near work survived. This might explain why, over the generations, myopia has become prevalent among the Chinese.

There are many studies to slow down the progress of myopia — eye exercises, eye massages, avoidance of prolonged reading, use of Atropine, use of large letters on white or black boards in school and a host of other methods.

Many have sought alternatives to the use of spectacles. Contact lenses became popular but their use is not without problems. In fact, the use of soft lenses can lead to infection which has caused blindness. When the patient is 20-year or older, his vision can be improved with surgery, the most popular of which is the use of the excimer laser. More recently, LASIK — where a thin layer of the cornea is lifted before the application of laser — has been used. There are now several new lasers and methods of refractive surgery being introduced. This book addresses myopia and I believe that readers will find it useful in their understanding of the condition.

I am delighted that this publication is dedicated to one of the world’s most enthusiastic researchers on myopia — the late Dr Sek-Jin Chew who was also my student, my friend and a leader of research at the National University of Singapore. We founded the Singapore Eye Research Institute (SERI) of which he was the founding deputy director. Sek Jin’s intense interest in myopia has made Singapore one of the world’s leading centres for myopic studies.

While we wait for research to give us more answers, this book is a useful guide for anyone wishing to learn more about myopia.

Professor Arthur Lim, MD (Hon), FRCS

Founding Chairman

Singapore Eye Research Institute

Contents

Foreword

v

Dedication

ix

Message

xiii

About the Editors

xix

List of Contributors

xxiii

Acknowledgments

xxvii

Section 1

Epidemiology and Risk Factors

1

Chapter 1.1 Epidemiology of Myopia and Myopic Shift

3

 

in Refraction

 

 

Barbara E.K. Klein

 

Chapter 1.2

Environmental Risk Factors for Myopia in Children

23

 

Wilson C.J. Low, Tien-Yin Wong and Seang-Mei Saw

 

Chapter 1.3

Gene-Environment Interactions in the Aetiology

45

 

of Myopia

 

 

Ian G. Morgan and Kathryn A. Rose

 

Chapter 1.4

The Economics of Myopia

63

 

Marcus C.C. Lim and Kevin D. Frick

 

xv

xvi Contents

Section 2

Clinical Studies and Pathologic Myopia

81

Chapter 2.1 Quality of Life and Myopia

83

 

Ecosse L. Lamoureux and Hwee-Bee Wong

 

Chapter 2.2 Ocular Morbidity of Pathological Myopia

97

 

V. Swetha E. Jeganathan, Seang-Mei Saw

 

 

and Tien-Yin Wong

 

Chapter 2.3

Myopia and Glaucoma

121

 

Shamira A. Perera and Tin Aung

 

Chapter 2.4

The Myopic Retina

137

 

Shu-Yen Lee

 

Chapter 2.5

Retinal Function

149

 

Chi D. Luu and Audrey W.L. Chia

 

Section 3

Genetics of Myopia

161

Chapter 3.1

New Approaches in the Genetics of Myopia

163

 

Liang K. Goh, Ravikanth Metlapally

 

 

and Terri Young

 

Chapter 3.2

Twins Studies and Myopia

183

 

Maria Schäche and Paul N. Baird

 

Chapter 3.3

TIGR, TGFB1, cMET, HGF, Collagen Genes,

201

 

and Myopia

 

 

Chiea-Chuen Khor

 

Chapter 3.4

Statistical Analysis of Genome-wide Association

215

 

Studies for Myopia

 

 

Yi-Ju Li and Qiao Fan

 

xvii Contents

Section 4

Animal Models and the Biological Basis

237

 

of Myopia

 

Chapter 4.1 The Relevance of Studies in Chicks for

239

 

Understanding Myopia in Humans

 

 

Josh Wallman and Debora L. Nickla

 

Chapter 4.2

The Mechanisms Regulating Scleral Change

267

 

in Myopia

 

 

Neville A. McBrien

 

Chapter 4.3

The Mouse Model of Myopia

303

 

Frank Schaeffel

 

Chapter 4.4

Gene Analysis in Experimental Animal Models

331

 

of Myopia

 

 

Roger W. Beuerman, Liang K. Goh and

 

 

Veluchamy A. Barathi

 

Section 5

Interventions for Myopia

343

Chapter 5.1

Atropine and Other Pharmacological Approaches

345

 

to Prevent Myopia

 

 

Louis M.G. Tong, Veluchamy A. Barathi

 

 

and Roger W. Beuerman

 

Chapter 5.2

Physical Factors in Myopia and Potential

361

 

Therapies

 

 

Wallace S. Foulds and Chi D. Luu

 

Index

 

387

This page intentionally left blank